Lexicon Pharmaceuticals, Inc. (LXRX)
1.645
+0.04
(+2.81%)
USD |
NASDAQ |
May 07, 14:41
Lexicon Pharmaceuticals SG&A Expense (TTM) : 37.32M for Dec. 31, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Viemed Healthcare, Inc. | 99.76M |
| ANI Pharmaceuticals, Inc. | 317.74M |
| Novavax, Inc. | 109.39M |
| Kura Oncology, Inc. | 119.98M |
| Liquidia Corp. | 157.18M |